Ren Q - Search Results

1

Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.

Tian J, Wang Y, Zhang X, Ren Q, Li R, Huang Y, Lu H, Chen J. Tian J, et al. Among authors: ren q. J Exp Clin Cancer Res. 2017 Nov 2;36(1):153. doi: 10.1186/s13046-017-0625-y. J Exp Clin Cancer Res. 2017. PMID: 29096683 Free PMC article.

2

Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.

Zhao X, Li X, Ren Q, Tian J, Chen J. Zhao X, et al. Among authors: ren q. Gene. 2016 Oct 10;591(1):123-128. doi: 10.1016/j.gene.2016.07.012. Epub 2016 Jul 5. Gene. 2016. PMID: 27393650

3

Correction to: Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.

Tian J, Wang Y, Zhang X, Ren Q, Li R, Huang Y, Lu H, Chen J. Tian J, et al. Among authors: ren q. J Exp Clin Cancer Res. 2017 Dec 15;36(1):184. doi: 10.1186/s13046-017-0660-8. J Exp Clin Cancer Res. 2017. PMID: 29298702 Free PMC article.

4

Neuroprotective Mechanisms of Calycosin Against Focal Cerebral Ischemia and Reperfusion Injury in Rats.

Wang Y, Ren Q, Zhang X, Lu H, Chen J. Wang Y, et al. Among authors: ren q. Cell Physiol Biochem. 2018;45(2):537-546. doi: 10.1159/000487031. Epub 2018 Jan 25. Cell Physiol Biochem. 2018. PMID: 29402799 Free article.

5

Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.

Wang Y, Xie W, Hou M, Tian J, Zhang X, Ren Q, Huang Y, Chen J. Wang Y, et al. Among authors: ren q. Aging (Albany NY). 2021 Mar 1;13(8):11026-11042. doi: 10.18632/aging.202641. Epub 2021 Mar 1. Aging (Albany NY). 2021. PMID: 33647882 Free PMC article.

6

Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.

Xin M, Wang Y, Ren Q, Guo Y. Xin M, et al. Among authors: ren q. Biomed Pharmacother. 2019 Jan;109:2084-2089. doi: 10.1016/j.biopha.2018.09.033. Epub 2018 Nov 26. Biomed Pharmacother. 2019. PMID: 30551465 Free article.

7

NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways.

Li B, Zhang X, Ren Q, Gao L, Tian J. Li B, et al. Among authors: ren q. Front Pharmacol. 2022 Jan 10;12:781623. doi: 10.3389/fphar.2021.781623. eCollection 2021. Front Pharmacol. 2022. PMID: 35082669 Free PMC article.

8

Correction for: Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.

Wang Y, Xie W, Hou M, Tian J, Zhang X, Ren Q, Huang Y, Chen J. Wang Y, et al. Among authors: ren q. Aging (Albany NY). 2022 Mar 14;14(5):2434-2435. doi: 10.18632/aging.203953. Epub 2022 Mar 14. Aging (Albany NY). 2022. PMID: 35288485 Free PMC article. No abstract available.

9

Formononetin, J1 and J2 have different effects on endothelial cells via EWSAT1-TRAF6 and its downstream pathway.

Li X, Huang C, Sui CL, Liang CM, Qi GY, Ren QY, Chen J, Huang ZQ. Li X, et al. J Cell Mol Med. 2020 Jan;24(1):875-885. doi: 10.1111/jcmm.14797. Epub 2019 Nov 19. J Cell Mol Med. 2020. PMID: 31742893 Free PMC article.

10

Risk stratification based on changes in the standard maximal uptake value on PET/CT and the plasma Epstein‒Barr virus (EBV) DNA status after two cycles of chemotherapy for extranodal NK-/T-cell lymphoma.

Ren Q, Cui Y, Wang Z, Fang X, Chen M, Chen Z, Lin T, Jiang Y, Huang H. Ren Q, et al. Ann Hematol. 2024 Dec 27. doi: 10.1007/s00277-024-06149-1. Online ahead of print. Ann Hematol. 2024. PMID: 39725700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,324 results

Search Page

Filters